Advanced

Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.

Styring, Emelie LU ; Fernebro, Josefin LU ; Jönsson, Per-Ebbe LU ; Ehinger, Anna LU ; Engellau, Jacob LU ; Rissler, Pehr LU ; Rydholm, Anders LU ; Nilbert, Mef LU and Vult von Steyern, Fredrik LU (2010) In Breast Cancer Research and Treatment 122. p.883-887
Abstract
Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females... (More)
Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females treated by segmental resection, anti-hormonal treatment and radiotherapy 1980-2005 developed angiosarcomas in the irradiated field on the thoracic wall after median 7.3 years. The clinical presentations were heterogeneous and included hematoma-like lesions, multiple bluish-reddish nodules, and asymptomatic lumps. The overall 5-year survival was 16%. In this population-based cohort, the early angiosarcomas developed in edematous arms after radical mastectomies, whereas more recent cases occurred after a shorter time period in the irradiated fields following breast conserving surgery. We conclude that the clinical presentation of angiosarcomas has changed, parallel with altered treatment principles for breast cancer. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Breast Cancer Research and Treatment
volume
122
pages
883 - 887
publisher
Springer
external identifiers
  • WOS:000280062600029
  • PMID:20087653
  • Scopus:77955558896
ISSN
1573-7217
DOI
10.1007/s10549-009-0703-8
language
English
LU publication?
yes
id
9a081150-a91a-453e-83df-4cf17e6fa4a7 (old id 1540802)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20087653?dopt=Abstract
date added to LUP
2010-02-03 09:49:25
date last changed
2016-10-23 04:31:20
@misc{9a081150-a91a-453e-83df-4cf17e6fa4a7,
  abstract     = {Angiosarcoma is a rare complication of breast cancer treatment. In order to define predictors, clinical presentation, and outcome, we characterized a population-based 50-year cohort of angiosarcomas after breast cancer. Clinical data were collected from all females with previous breast cancer who developed angiosarcomas/lymphangiosarcomas on the thoracic wall/upper extremity between 1958 and 2008 in the Southern Swedish health care region. In total, 31 angiosarcomas developed at a median age of 71 years. The patients formed two distinct groups; 14 females treated for breast cancer with radical mastectomy and radiotherapy 1949-1988 developed angiosarcomas in edematous arms (Stewart-Treves syndrome) after median 11 years, and 17 females treated by segmental resection, anti-hormonal treatment and radiotherapy 1980-2005 developed angiosarcomas in the irradiated field on the thoracic wall after median 7.3 years. The clinical presentations were heterogeneous and included hematoma-like lesions, multiple bluish-reddish nodules, and asymptomatic lumps. The overall 5-year survival was 16%. In this population-based cohort, the early angiosarcomas developed in edematous arms after radical mastectomies, whereas more recent cases occurred after a shorter time period in the irradiated fields following breast conserving surgery. We conclude that the clinical presentation of angiosarcomas has changed, parallel with altered treatment principles for breast cancer.},
  author       = {Styring, Emelie and Fernebro, Josefin and Jönsson, Per-Ebbe and Ehinger, Anna and Engellau, Jacob and Rissler, Pehr and Rydholm, Anders and Nilbert, Mef and Vult von Steyern, Fredrik},
  issn         = {1573-7217},
  language     = {eng},
  pages        = {883--887},
  publisher    = {ARRAY(0x9a2d090)},
  series       = {Breast Cancer Research and Treatment},
  title        = {Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.},
  url          = {http://dx.doi.org/10.1007/s10549-009-0703-8},
  volume       = {122},
  year         = {2010},
}